Financhill
Back

Arbutus Biopharma Vs. GlycoMimetics Industry Stock Comparison

Sell
37

ABUS
Arbutus Biopharma

Last Price:
3.41
Seasonality Move:
24.22%
Sell
50

GLYC
GlycoMimetics

Last Price:
0.32
Seasonality Move:
11.03%
Sell
37
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.41. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy, Sell or Hold?

  • The current GlycoMimetics [GLYC] share price is $0.32. The Score for GLYC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • GLYC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight selling pressure.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

  • The GlycoMimetics share price today is $0.32
    The current trend is moderately bearish and GLYC is experiencing slight buying pressure.

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 30.86 Sell
Chaikin Money Flow: -303520 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.53 - 3.97) Sell
Bollinger Bands (100): (3.59 - 4.11) Sell

GLYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 48.97 Sell
Chaikin Money Flow: 296581 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.26 - 0.44) Sell
Bollinger Bands (100): (0.14 - 0.32) Buy

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.49 Sell
20-day SMA: 3.68 Sell
50-day SMA: 3.85 Sell
200-day SMA: 3.39 Buy
8-day EMA: 3.5 Sell
20-day EMA: 3.64 Sell
50-day EMA: 3.77 Sell
200-day EMA: 3.43 Sell

GLYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.35 Sell
20-day SMA: 0.38 Sell
50-day SMA: 0.26 Buy
200-day SMA: 0.93 Sell
8-day EMA: 0.34 Sell
20-day EMA: 0.34 Sell
50-day EMA: 0.3 Buy
200-day EMA: 0.73 Sell

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

GlycoMimetics Earnings Growth & GLYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

GlycoMimetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):